SAXAGLIPTIN ANHYDROUS
UNII 8I7IO46IVQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Saxagliptin Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8I7IO46IVQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 361442-04-8 and the RxNorm Concept ID (RxCUI) 1546030. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8I7IO46IVQ

CAS Registry Number

361442-04-8

RxNorm Concept ID

1546030

Detailed Substance Profile

Preferred Name

SAXAGLIPTIN ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

8I7IO46IVQ

The specific atomic composition represented as a molecular structure string.

InChIKey

C18H25N3O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QGJUIPDUBHWZPV-SGTAVMJGSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C75984

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11243969

Unique identification number in the NCBI database of chemical substances.

INN ID

8577

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1([C@@]2([C@](C[C@H]1C#N)(C2)[H])[H])C(=O)[C@@H](N)C34CC5(CC(C3)CC(C4)C5)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Saxagliptin Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.